Trinity Biotech (TRIB) Regains Nasdaq Compliance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Trinity Biotech Regains Compliance with Nasdaq Listing Requirements
November 7, 2024 8:19 AM ESTDUBLIN, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq Global Select: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that on November 6, 2024, it received written notice from the Nasdaq Stock Market LLC (Nasdaq) confirming that the Company has regained compliance with the minimum market value of publicly held shares (MVPHS) requirement under Nasdaq Listing Rule 5450(b)(2)(C) (the MVPHS Requirement).
One of my top priorities when taking on the role of CEO last December was to address the pre-existing Nasdaq listing... More



